Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 851-900 of 1653 result(s).
CYDY CytoDyn Inc
11/06/2020 11:40:05 AM
nmbr1, Completely my fault. I apolo (1)
CYDY CytoDyn Inc
11/06/2020 11:15:11 AM
Jake, Thanks. You are correct. My w
CYDY CytoDyn Inc
11/06/2020 10:55:11 AM
Jake, As Lorbas noted, I completely
CYDY CytoDyn Inc
11/06/2020 9:36:17 AM
Calstang, Good question. I believe (2)
CYDY CytoDyn Inc
11/06/2020 9:25:46 AM
Humanigen stock up on DSMC recommen
CYDY CytoDyn Inc
11/05/2020 3:55:24 PM
I would put the onus on the hospita (1)
CYDY CytoDyn Inc
11/05/2020 12:37:28 PM
Looks like the trial site is in Col (2)
CYDY CytoDyn Inc
11/03/2020 3:56:47 PM
Craigakess, Clawing back to 2.7! An (1)
CYDY CytoDyn Inc
11/03/2020 3:16:47 PM
Ken, Great news and strong work. I
CYDY CytoDyn Inc
11/03/2020 10:57:13 AM
Expharmer, From what I have gleaned
CYDY CytoDyn Inc
11/03/2020 10:55:19 AM
Plenty of support for leronlimab fr (4)
CYDY CytoDyn Inc
11/03/2020 8:47:17 AM
Jeff, I share your disappointment, (4)
CYDY CytoDyn Inc
11/02/2020 12:18:01 PM
Calstang, In these trials patients (2)
CYDY CytoDyn Inc
11/02/2020 9:11:50 AM
Dfwl28, No one wants to stick his n (2)
CYDY CytoDyn Inc
11/01/2020 6:44:39 PM
David, I believe management is awar (6)
CYDY CytoDyn Inc
11/01/2020 5:51:41 PM
David, We all make our own investme (6)
CYDY CytoDyn Inc
11/01/2020 5:00:01 PM
David, The DSMB is selected by Cyto (9)
CYDY CytoDyn Inc
11/01/2020 1:19:07 AM
Designing a new anti-viral mAb to m (2)
CYDY CytoDyn Inc
10/30/2020 8:30:34 PM
FKAdam, A good reminder to all of u (3)
CYDY CytoDyn Inc
10/30/2020 8:51:40 AM
Bruce Patterson tweeted yesterday: (1)
CYDY CytoDyn Inc
10/30/2020 8:45:31 AM
Nicehedges, Nice! Sorry, I’m most (4)
CYDY CytoDyn Inc
10/29/2020 7:57:19 PM
Smurph, Leronlimab not trialed at t (1)
CYDY CytoDyn Inc
10/29/2020 6:27:03 PM
Tocilizumab Stumbles as COVID-19 Tr (5)
CYDY CytoDyn Inc
10/29/2020 4:22:29 PM
CDiddy, For what’s its worth the (1)
CYDY CytoDyn Inc
10/29/2020 4:02:41 PM
CDiddy, I missed that Mexico insist (2)
CYDY CytoDyn Inc
10/29/2020 3:41:09 PM
Cassandra, It was supposed to three (1)
CYDY CytoDyn Inc
10/29/2020 2:56:19 PM
Penny slayer, I am not brave or sav (3)
CYDY CytoDyn Inc
10/29/2020 1:29:42 PM
Dr. Acula, Agreed completely. Just (7)
CYDY CytoDyn Inc
10/29/2020 1:22:59 PM
Looks as though Gilead at lowest le (2)
CYDY CytoDyn Inc
10/29/2020 10:05:26 AM
Jlang, Agreed absolutely on all the (1)
CYDY CytoDyn Inc
10/29/2020 8:38:41 AM
I_luv, I believe it is more the cas (5)
CYDY CytoDyn Inc
10/29/2020 6:48:11 AM
Fsoalex, Reduced progression to sev (1)
CYDY CytoDyn Inc
10/28/2020 8:02:34 PM
Ritz, We have had a number of EMTs
CYDY CytoDyn Inc
10/28/2020 6:44:11 PM
Ritz, Get well soon. At least in CT
CYDY CytoDyn Inc
10/28/2020 5:28:44 PM
JC, It seems that it is the metabol (1)
CYDY CytoDyn Inc
10/28/2020 5:18:06 PM
Cassandra, It also appears that imm (2)
CYDY CytoDyn Inc
10/28/2020 4:19:09 PM
Thrifty, Here is a note from an AID (3)
CYDY CytoDyn Inc
10/27/2020 7:28:15 PM
J&J 385 B Roche 281 B Novartis 240 (1)
CYDY CytoDyn Inc
10/27/2020 4:06:14 PM
Tylenol if you’re clumsy (increas
CYDY CytoDyn Inc
10/27/2020 11:18:15 AM
Waning Covid antibodies over time. (4)
CYDY CytoDyn Inc
10/27/2020 10:34:05 AM
Ohm, I realized that after the repl (1)
CYDY CytoDyn Inc
10/27/2020 10:19:21 AM
CDIddy, You are correct. I'll look
CYDY CytoDyn Inc
10/27/2020 10:05:26 AM
Looks as though MHRA/EAM renders de (3)
CYDY CytoDyn Inc
10/27/2020 9:27:29 AM
Laundry, Maybe Philippines next. FO (3)
CYDY CytoDyn Inc
10/27/2020 6:35:25 AM
Flynteade, Cooperation among the th (3)
CYDY CytoDyn Inc
10/26/2020 8:58:09 PM
I would imagine: 1. A director alre (5)
CYDY CytoDyn Inc
10/26/2020 2:40:50 PM
Lawman, A very sage observation. Op (3)
CYDY CytoDyn Inc
10/26/2020 10:41:07 AM
Rubraquercus, Cytodyn has made reas (9)
CYDY CytoDyn Inc
10/26/2020 9:16:10 AM
https://www.sciencedirect.com/scie (9)
CYDY CytoDyn Inc
10/25/2020 6:38:14 PM
Havasu, CD12 is an adaptive trial. (2)
Go to page:
  • << First
  • < Previous
  • 17
  • 18
  • Next >

Recent Articles

  • Join the Excitement at the Stash Smash Tournament
  • Aja Health and Wellness Inc. Discusses Financial Reporting Delays
  • Transforming $100 In Parker Hannifin Stock Over Two Decades
  • Ram Vela Steps Up as Chief Strategy Officer at Vortex Companies
  • Analyzing Toast Inc.'s Current Market Position and P/E Ratio
  • A 15-Year Journey: Transforming $100 into Wealth with IES Hldgs
  • Investigation Launched into Simulations Plus, Inc. Shares
  • DermaRite Industries Initiates Nationwide Recall of Products
  • Airbnb's Growth Challenges: Analyzing Recent Earnings Report
  • Revolutionizing Digital Asset Management with GVNR Technology
  • Miata Metals Increases Private Placement to $5.5 Million
  • Miata Metals Secures $5.5 Million in Upsized Private Placement
  • Exploring the Growth of Freeport-McMoRan: Investment Insights
  • Iceland's Economic Outlook Brightens Amid Financial Progress
  • The Remarkable Five-Year Growth of Equitable Holdings (EQH)
  • First Nordic Metals Expands Incentive Stock Options Grant
  • Dr. Wazni Discusses Chronic Venous Insufficiency Insights
  • Zamansky LLC Investigates Broker-Dealers for Investor Losses
  • Navigating the Netflix Stock Landscape: Insights for Investors
  • Constellation Software Reports Q2 2025 Financial Performance
  • Lucara Diamond Corp's Impressive Q2 2025 Performance Report
  • Verde AgriTech Reveals Critical Insights on Q2 2025 Results
  • Celebrating Alumni Success Before the Emmy Awards
  • Investigation into RxSight, Inc. (RXST) Class Action Lawsuit
  • Novo Nordisk A/S Investors Alert: Class Action Update and Facts
  • Paul Mueller Company Declares Cash Dividend for Shareholders
  • What a $1000 Investment in Canadian Pacific Could Yield Now
  • Jeff Harsh Steps into COO Role at Advantage Solutions Inc
  • The Incredible Growth of a $100 Investment in Fabrinet
  • Rubicon Organics Plans Q2 2025 Financial Results Call
  • How a $100 Investment in HubSpot Changed Over 10 Years
  • Verde AgriTech Reports Resilient Q2 2025 Financial Performance
  • Ashland Inc Declares New Quarterly Dividend for Investors
  • Star Equity Holdings Announces Dividend and Merger Plan Details
  • Koil Energy Solutions Sets Conference Call for Q2 Earnings Results
  • Helios Fairfax Partners Reports Strong Growth in Q2 Results
  • The Impressive Journey of Live Nation Entertainment Stock Growth
  • Star Equity Holdings Announces Exciting Dividend Update
  • Lexin's Remarkable Q2 Growth: Profits Surge Amid Consumer Trends
  • Rubicon Organics Prepares to Share Q2 2025 Financial Insights
  • Exploring Finance of America Inc's Earnings and Market Position
  • Ocugen Secures $20 Million Through Direct Stock Offering
  • TELA Bio Grants Stock Units to Boost Employee Engagement
  • Prospect Park Capital Corp. Announces Key Developments
  • Investing in Gold Miners: A Rising Opportunity in Finance
  • Helios Fairfax Partners Reports Strong Q2 Growth Results
  • Ashland Inc. Declares Significant Quarterly Dividend for Shareholders
  • Ocugen Secures $20 Million to Boost Gene Therapy Innovations
  • Constellation Software Q2 Results: Solid Growth and Dividends
  • Dorel Industries Inc Sees Mixed Results Amidst Challenges
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site